118 related articles for article (PubMed ID: 22566065)
1. The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
Cai T; Malossini G; Bartoletti R
Cancer; 2012 Nov; 118(22):5719; author reply 5720. PubMed ID: 22566065
[No Abstract] [Full Text] [Related]
2. The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
Lotan Y
Cancer; 2012 May; 118(10):2566-7. PubMed ID: 21918966
[No Abstract] [Full Text] [Related]
3. The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
Abogunrin F; O'Kane HF; Ruddock MW; Stevenson M; Reid CN; O'Sullivan JM; Anderson NH; O'Rourke D; Duggan B; Lamont JV; Boyd RE; Hamilton P; Nambirajan T; Williamson KE
Cancer; 2012 May; 118(10):2641-50. PubMed ID: 21918968
[TBL] [Abstract][Full Text] [Related]
4. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
Piao XM; Jeong P; Kim YH; Byun YJ; Xu Y; Kang HW; Ha YS; Kim WT; Lee JY; Woo SH; Kwon TG; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
Int J Cancer; 2019 Jan; 144(2):380-388. PubMed ID: 30183088
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic tests used in the investigation of adult haematuria: A systematic review.
Rodgers MA; Hempel S; Aho T; Kelly JD; Kleijnen J; Westwood M
BJU Int; 2006 Dec; 98(6):1154-60. PubMed ID: 16879444
[No Abstract] [Full Text] [Related]
6. Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.
Butt E; Ebbing J; Bubendorf L; Ardelt P
Biomark Med; 2017 Apr; 11(4):347-357. PubMed ID: 28290211
[TBL] [Abstract][Full Text] [Related]
7. Re: The BTA stat test is nonspecific for hematuria: an experimental hematuria model.
Kinders RJ; Landicho H
J Urol; 2002 Dec; 168(6):2556; author reply 2556-7. PubMed ID: 12441978
[No Abstract] [Full Text] [Related]
8. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
9. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
[TBL] [Abstract][Full Text] [Related]
10. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
11. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
[TBL] [Abstract][Full Text] [Related]
12. [Hematuria].
Blöchlinger AM; Gasser TC; Stoffel F; Laschke S; Bühring C
Ther Umsch; 1996 Sep; 53(9):672-5. PubMed ID: 8966694
[TBL] [Abstract][Full Text] [Related]
13. [Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].
Adolphs HD; Oehr P
Helv Chir Acta; 1982 Aug; 49(3-4):307-11. PubMed ID: 7129893
[No Abstract] [Full Text] [Related]
14. Occupational bladder cancer: from cohort study to biologic molecular marker.
Matsumoto K; Irie A; Satoh T; Kuruma H; Arakawa T; Baba S
Med Sci Monit; 2005 Oct; 11(10):RA311-5. PubMed ID: 16192913
[TBL] [Abstract][Full Text] [Related]
15. [The application of BTA stat in the diagnosis of bladder tumor and hematuria].
Wang X; Xu K; Zhu J; Hou S
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):228-30. PubMed ID: 11829827
[TBL] [Abstract][Full Text] [Related]
16. Hematuria: a problem-based imaging algorithm illustrating the recent Dutch guidelines on hematuria.
van der Molen AJ; Hovius MC
AJR Am J Roentgenol; 2012 Jun; 198(6):1256-65. PubMed ID: 22623537
[TBL] [Abstract][Full Text] [Related]
17. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
[TBL] [Abstract][Full Text] [Related]
18. Protein profiling in urine for the diagnosis of bladder cancer.
Vlahou A; Giannopoulos A; Gregory BW; Manousakas T; Kondylis FI; Wilson LL; Schellhammer PF; Wright GL; Semmes OJ
Clin Chem; 2004 Aug; 50(8):1438-41. PubMed ID: 15277356
[No Abstract] [Full Text] [Related]
19. Biochemical and immunologic diagnosis of cancer. Urinary immunocytology and bladder carcinomas.
Arndt R; Huland H
Tumour Biol; 1987; 8(2-3):105. PubMed ID: 3448761
[No Abstract] [Full Text] [Related]
20. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
